Connection
Cindy O'Bryant to Vascular Endothelial Growth Factor Receptor-1
This is a "connection" page, showing publications Cindy O'Bryant has written about Vascular Endothelial Growth Factor Receptor-1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.020 |
|
|
|
-
Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. J Clin Oncol. 2010 Feb 10; 28(5):780-7.
Score: 0.020